 EMERYVILLE, Calif.--BUSINESS WIRE--Adamas Pharmaceuticals, Inc. Nasdaq: ADMS, a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that the organization will be participating in two upcoming June conferences: Christopher B. Prentiss, Chief Financial Officer will present at the William Blair 41st Annual Growth Stock Conference on Thursday, June 3 2021 at 11:00 am Eastern Time. Neil F. McFarla 